| No headlines available for VCHSX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 166.23M | | Category: | Health | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 25.47% | | 5y Avg Return: | 6.45% | | Rank in Category (ytd): | 23 | | % Rank in Category (ytd): | 13.94% | | Beta (3y): | 0.84 | | Morningstar Risk Rating: | Above average |
|
| The investment seeks long-term capital growth. The fund normally invests at least 80% of assets in the common stocks of companies engaged in "health sciences", including research, development, production, or distribution of products or services related to health care, medicine, or the life science. It may invest up to 35% of total assets in foreign stocks, which include non-dollar denominated securities traded outside the U.S. The fund is nondiversified. | | | Fund Profile |
|
Help
0.10 (1.11%) 
Summary
Add VCHSX to Portfolio 
Download Data
